How Much Reliable iv Calcium for the Treatment of Hyperkalemia?
1 other identifier
observational
111
1 country
1
Brief Summary
Hyperkalemia is a common problem in the emergency services and one of the life threatening metabolic emergencies. Calcium, insulin, beta adrenoceptor agonists, bicarbonate, diuretics, sodium polystyrene sulfonate and lastly dialysis are advised in treatment. Especially, avoiding evolution of serious arrythmias and iv calcium using in the treatment of occured electrocardiogram (ECG) abnormalities, there is not sufficient level of survey in the literature. So the aim of this study was to evaluate administration of iv calcium efficiency on vital signs and ECG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 17, 2016
CompletedFirst Posted
Study publicly available on registry
February 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedMarch 2, 2021
September 1, 2020
1 year
January 17, 2016
February 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ECG changes after the calcium infusion
10 minutes
Secondary Outcomes (2)
Pulse changes after the calcium infusion
10 minutes
Blood pressure changes after the calcium infusion
10 minutes
Interventions
ECG and vital parameters were obtained before and after recommended standard calcium gluconate therapy for hyperkalemia
Eligibility Criteria
Blood potassium levels above 5.5 and all patients with ECG changes due hyperpotassemia were included in the study.
You may qualify if:
- All patients who had ECG changes due to hyperpotassemia (K\>5.5 mmol/l)
You may not qualify if:
- Arrest patients
- Patients needed antiarrhythmic interventions
- Patients need inotropic that may cause ECG changes
- Patients need atropine during emergency treatment prior to Ca-gluconate
- Patients needed cardioversion or defibrillation
- Hyperpotassemia with myocardial infarction
- In the presence of other situations which changes ECG for example pericarditis
- Unstabile patients for ideal ECG
- Digoxin usage
- Trauma
- blood calcium level of \> 10.5 mg/dl
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haseki Training and Reseurch Hospital
Istanbul, 34096, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adnan Yamanoğlu, MD
Emergency Department
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Emergency Medicine Specialist
Study Record Dates
First Submitted
January 17, 2016
First Posted
February 3, 2016
Study Start
July 1, 2015
Primary Completion
July 1, 2016
Study Completion
July 1, 2017
Last Updated
March 2, 2021
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share